ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 965,19
1,87%
DAX
18 518,03
-0,44%
Brent Oil
83,265
-1,27%
Bitcoin
65 063,24
0,33%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
04/12/201317h44Business WireTeva to Host 2014 Business Outlook Conference Call and Webcast on December 10, 2013NYSE:TEVATeva Pharmaceutical Industries Ltd
04/12/201314h00Business Wire“Dancing with the Stars” Finalist Jack Osbourne Offers Inside Look at His Life with Multiple Sclerosis through You Don’...NYSE:TEVATeva Pharmaceutical Industries Ltd
04/12/201312h51Business WireTeva In-Focus: A Webinar Series for the Investment Community Focusing on Teva’s R&D ActivitiesNYSE:TEVATeva Pharmaceutical Industries Ltd
04/12/201308h27Business WireTeva and Takeda Announce Agreement for Glatiramer Acetate for Multiple Sclerosis Treatment in JapanNYSE:TEVATeva Pharmaceutical Industries Ltd
27/11/201314h06Business WireTeva Announces Additional Regulatory Exclusivity for TREANDA® (Bendamustine HCI) for InjectionNYSE:TEVATeva Pharmaceutical Industries Ltd
25/11/201314h55Business WireTeva and Mylan Settle Copaxone® Patent Litigation in France, the UK and the NetherlandsNYSE:TEVATeva Pharmaceutical Industries Ltd
25/11/201306h42Business WireTeva Comments on Recent ArticleNYSE:TEVATeva Pharmaceutical Industries Ltd
19/11/201316h03Business WireTeva in Focus: New Therapeutic Entities - from Process to ProductNYSE:TEVATeva Pharmaceutical Industries Ltd
19/11/201312h30PR Newswire (US)OncoGenex Announces Update on Phase 3 SYNERGY Trial Evaluating Custirsen in Men with Metastatic Castrate-Resistant Prostate C...NYSE:TEVATeva Pharmaceutical Industries Ltd
18/11/201314h05Business WireTeva Announces Updates to Oncology Biologic PortfolioNYSE:TEVATeva Pharmaceutical Industries Ltd
15/11/201315h18Dow Jones NewsOZ Management LP 3Q 13F: Holdings As Of Sep 30NYSE:TEVATeva Pharmaceutical Industries Ltd.
15/11/201315h18Dow Jones NewsOZ Management LP 3Q 13F: Holdings As Of Sep 30 -2-NYSE:TEVATeva Pharmaceutical Industries Ltd
15/11/201315h17Dow Jones NewsOZ Management LP 3Q 13F: Largest SalesNYSE:TEVATeva Pharmaceutical Industries Ltd.
15/11/201315h10Dow Jones NewsCaxton Associates LP 3Q 13F: Largest EliminationsNYSE:TEVATeva Pharmaceutical Industries Ltd.
15/11/201315h10Dow Jones NewsCaxton Associates LP 3Q 13F: Holdings As Of Sep 30 -2-NYSE:TEVATeva Pharmaceutical Industries Ltd
15/11/201315h10Dow Jones NewsCaxton Associates LP 3Q 13F: Holdings As Of Sep 30NYSE:TEVATeva Pharmaceutical Industries Ltd
15/11/201315h01Dow Jones NewsHBK Investments LP 3Q 13F: Holdings As Of Sep 30 -2-NYSE:TEVATeva Pharmaceutical Industries Ltd
15/11/201315h01Dow Jones NewsHBK Investments LP 3Q 13F: Holdings As Of Sep 30NYSE:TEVATeva Pharmaceutical Industries Ltd.
15/11/201314h58Dow Jones NewsHighfields Capital Management LP 3Q 13F: Holdings As Of Sep 30NYSE:TEVATeva Pharmaceutical Industries Ltd.
15/11/201314h58Dow Jones NewsHighfields Capital Management LP 3Q 13F: Largest EliminationsNYSE:TEVATeva Pharmaceutical Industries Ltd.
15/11/201314h53Dow Jones NewsD. E. Shaw & Co. LP 3Q 13F: Holdings As Of Sep 30 -2-NYSE:TEVATeva Pharmaceutical Industries Ltd
15/11/201314h53Dow Jones NewsD. E. Shaw & Co. LP 3Q 13F: Holdings As Of Sep 30NYSE:TEVATeva Pharmaceutical Industries Ltd.
15/11/201314h39Dow Jones NewsKingdon Capital Management 3Q 13F: Largest EliminationsNYSE:TEVATeva Pharmaceutical Industries Ltd.
15/11/201314h39Dow Jones NewsKingdon Capital Management 3Q 13F: Holdings As Of -2-NYSE:TEVATeva Pharmaceutical Industries Ltd
15/11/201314h39Dow Jones NewsKingdon Capital Management 3Q 13F: Holdings As Of Sep 30NYSE:TEVATeva Pharmaceutical Industries Ltd
15/11/201314h22Dow Jones NewsJanus Capital Management 3Q 13F: Largest Purchases -2-NYSE:TEVATeva Pharmaceutical Industries Ltd.
15/11/201314h22Dow Jones NewsJanus Capital Management 3Q 13F: Largest PurchasesNYSE:TEVATeva Pharmaceutical Industries Ltd
15/11/201313h59Dow Jones NewsSoros Fund Management 3Q 13F: Largest PurchasesNYSE:TEVATeva Pharmaceutical Industries Ltd
15/11/201313h59Dow Jones NewsSoros Fund Management 3Q 13F: Holdings As Of Sep -2-NYSE:TEVATeva Pharmaceutical Industries Ltd.
15/11/201313h59Dow Jones NewsSoros Fund Management 3Q 13F: Holdings As Of Sep 30NYSE:TEVATeva Pharmaceutical Industries Ltd.
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

NASDAQ
VC
Visteon
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés